Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News ENDRA Life Sciences Inc NDRA

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into... see more

Recent & Breaking News (NDAQ:NDRA)

ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021

Accesswire August 2, 2021

ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021

Accesswire July 20, 2021

ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents

Accesswire July 7, 2021

ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells

Accesswire June 15, 2021

ENDRA Life Sciences Set to Join the Russell Microcap(R) Index

Accesswire June 9, 2021

ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update

Accesswire May 17, 2021

ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021

Accesswire May 6, 2021

ENDRA Life Sciences Further Strengthens TAEUS(R) System's Intellectual Property Protection with Issuance of Two U.S. Patents

Accesswire May 4, 2021

ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting

Accesswire April 8, 2021

ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update

Accesswire March 25, 2021

ENDRA Life Sciences and Hepion Pharmaceuticals Partner to Drive Efficiencies in NASH Clinical Trials

Accesswire March 18, 2021

ENDRA Life Sciences to Report Fourth Quarter 2020 Financial Results on March 25, 2021

Accesswire March 17, 2021

ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences

Accesswire March 2, 2021

ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland

Accesswire February 17, 2021

ENDRA Life Sciences Further Strengthens TAEUS(R) System Intellectual Property Protection with Issuance of 14th U.S. Patent

Accesswire January 26, 2021

ENDRA Life Sciences Granted 13th U.S. Patent for its TAEUS(R) Platform Technology

Accesswire January 13, 2021

ENDRA Life Sciences to Present at H.C. Wainwright Virtual BioConnect 2021 Conference

Accesswire January 8, 2021

ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue

Accesswire December 23, 2020

ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years

Accesswire December 21, 2020

ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option

Accesswire December 18, 2020